Literature DB >> 9360533

Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome.

C Grunfeld1, W Doerrler, M Pang, P Jensen, K H Weisgraber, K R Feingold.   

Abstract

Given the important role of apolipoprotein E (apoE) in triglyceride metabolism, we analyzed plasma levels and degree of sialylation of apoE in subjects with the acquired immunodeficiency syndrome (AIDS), a disorder accompanied by hypertriglyceridemia. Levels of apoE were significantly increased (1.84-fold) and correlated with plasma triglycerides (r = .663, P < .001) in AIDS. Subjects with AIDS and the apoE3/E2 phenotype showed the most prominent increases in both plasma triglyceride and apoE levels (3.4 and 2.2-fold over controls). Additionally, apoE from subjects with AIDS showed an increased amount of sialylation, compared with controls (34% increase in apoE3/E3 subjects). Increased sialylation correlated with the increase in apoE levels. In contrast, there was no increase in sialylation of apo C-III in AIDS. Thus, triglyceride levels in AIDS are influenced by apoE subtype and subjects with AIDS show changes in apoE structure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360533     DOI: 10.1210/jcem.82.11.4366

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.

Authors:  Grace A Lee; Madhu N Rao; Carl Grunfeld
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

2.  Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, Tanzania.

Authors:  Catharina Armstrong; Enju Liu; James Okuma; Donna Spiegelman; Chalamilla Guerino; Marina Njelekela; Steve Grinspoon; Wafaie Fawzi; Claudia Hawkins
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

3.  The Effects of HIV Protease Inhibitors on Carbohydrate and Lipid Metabolism.

Authors:  Grace A Lee; Madhu N Rao; Carl Grunfeld
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

4.  ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice.

Authors:  Zhi H Huang; Catherine A Reardon; Papasani V Subbaiah; Godfrey S Getz; Theodore Mazzone
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

Review 5.  Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.

Authors:  Erdembileg Anuurad; Alison Semrad; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-10       Impact factor: 1.894

Review 6.  Evaluation and management of dyslipidemia in patients with HIV infection.

Authors:  Michael L Green
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.